PolyActiva Pty Ltd. products

For development of best-in-class ocular implants that deliver the right amount of drug, for the right period. Our technology is based on extensive scientific research leveraging our expertise in pharmaceutical, organic and polymer chemistry. The result is the creation of a unique method for precise and controlled drug delivery. Since many eye diseases are lifelong chronic disorders, a reliable and sustained delivery technology can remove the treatment burden on both patients and providers and have the potential to improve quality of life and patient outcomes.

Being developed to reduce IOP caused by Open-Angle Glaucoma & Ocular Hypertension. Clinical Investigation Stage: Phase II.

Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase I.